113 related articles for article (PubMed ID: 11672913)
21. Recombinant Marek's Disease Virus as a Vector-Based Vaccine against Avian Leukosis Virus Subgroup J in Chicken.
Liu Y; Li K; Gao Y; Gao L; Zhong L; Zhang Y; Liu C; Zhang Y; Wang X
Viruses; 2016 Nov; 8(11):. PubMed ID: 27827933
[TBL] [Abstract][Full Text] [Related]
22. In ovo vaccination of specific-pathogen-free chickens with vaccines containing multiple agents.
Gagic M; St Hill CA; Sharma JM
Avian Dis; 1999; 43(2):293-301. PubMed ID: 10396643
[TBL] [Abstract][Full Text] [Related]
23. Generation and evaluation of a recombinant Newcastle disease virus strain R2B with an altered fusion protein cleavage site as a vaccine candidate.
Yadav K; Pathak DC; Saikia DP; Debnath A; Ramakrishnan S; Dey S; Chellappa MM
Microb Pathog; 2018 May; 118():230-237. PubMed ID: 29578068
[TBL] [Abstract][Full Text] [Related]
24. Cellular responses in chickens treated with IFN-alpha orally or inoculated with recombinant Marek's disease virus expressing IFN-alpha.
Jarosinski KW; Jia W; Sekellick MJ; Marcus PI; Schat KA
J Interferon Cytokine Res; 2001 May; 21(5):287-96. PubMed ID: 11429159
[TBL] [Abstract][Full Text] [Related]
25. Protection and synergism by recombinant fowl pox vaccines expressing genes from Marek's disease virus.
Nazerian K; Witter RL; Lee LF; Yanagida N
Avian Dis; 1996; 40(2):368-76. PubMed ID: 8790888
[TBL] [Abstract][Full Text] [Related]
26. Application of a new bivalent Marek's disease vaccine does not interfere with infectious bronchitis or Newcastle disease vaccinations and proves efficacious.
Rahaus M; Augustinski K; Castells M; Desloges N
Avian Dis; 2013 Jun; 57(2 Suppl):498-502. PubMed ID: 23901767
[TBL] [Abstract][Full Text] [Related]
27. Newcastle disease virus vectored infectious laryngotracheitis vaccines protect commercial broiler chickens in the presence of maternally derived antibodies.
Yu Q; Spatz S; Li Y; Yang J; Zhao W; Zhang Z; Wen G; Garcia M; Zsak L
Vaccine; 2017 Feb; 35(5):789-795. PubMed ID: 28052812
[TBL] [Abstract][Full Text] [Related]
28. [Comparison of immunoprotection between vaccination with meq-deleted Marek's disease virus and vaccine strain CVI988/Rispens].
Duan L; Su S; Wang Y; Li S; Sun P; Chen W; Cui Z
Wei Sheng Wu Xue Bao; 2014 Nov; 54(11):1353-61. PubMed ID: 25752142
[TBL] [Abstract][Full Text] [Related]
29. Generation of a recombinant chimeric Newcastle disease virus vaccine that allows serological differentiation between vaccinated and infected animals.
Peeters BP; de Leeuw OS; Verstegen I; Koch G; Gielkens AL
Vaccine; 2001 Feb; 19(13-14):1616-27. PubMed ID: 11166884
[TBL] [Abstract][Full Text] [Related]
30. Complete, long-lasting protection against lethal infectious bursal disease virus challenge by a single vaccination with an avian herpesvirus vector expressing VP2 antigens.
Tsukamoto K; Saito S; Saeki S; Sato T; Tanimura N; Isobe T; Mase M; Imada T; Yuasa N; Yamaguchi S
J Virol; 2002 Jun; 76(11):5637-45. PubMed ID: 11991992
[TBL] [Abstract][Full Text] [Related]
31. [Experiments with the simultaneous or combined vaccination of chicks against Marek's disease and Newcastle disease].
Cholakova R; Stanilov Kh; Aleksiev N
Vet Med Nauki; 1978; 15(7):19-26. PubMed ID: 219586
[TBL] [Abstract][Full Text] [Related]
32. Recombinant infectious bursal disease virus expressing Newcastle disease virus (NDV) neutralizing epitope confers partial protection against virulent NDV challenge in chickens.
Li K; Gao L; Gao H; Qi X; Gao Y; Qin L; Wang Y; Wang X
Antiviral Res; 2014 Jan; 101():1-11. PubMed ID: 24200519
[TBL] [Abstract][Full Text] [Related]
33. A recombinant fowlpox virus vaccine expressing glycoprotein B gene from CVI988/Rispens strain of MDV: protection studies in different chickens.
Liu X; Peng D; Wu X; Xing L; Zhang R
Acta Virol; 1999; 43(2-3):201-4. PubMed ID: 10696446
[TBL] [Abstract][Full Text] [Related]
34. A recombinant Newcastle disease virus (NDV) expressing infectious laryngotracheitis virus (ILTV) surface glycoprotein D protects against highly virulent ILTV and NDV challenges in chickens.
Kanabagatte Basavarajappa M; Kumar S; Khattar SK; Gebreluul GT; Paldurai A; Samal SK
Vaccine; 2014 Jun; 32(28):3555-63. PubMed ID: 24793943
[TBL] [Abstract][Full Text] [Related]
35. Construction of Recombinant HVT Expressing PmpD, and Immunological Evaluation against Chlamydia psittaci and Marek's Disease Virus.
Liu S; Sun W; Chu J; Huang X; Wu Z; Yan M; Zhang Q; Zhao P; Igietseme JU; Black CM; He C; Li Y
PLoS One; 2015; 10(4):e0124992. PubMed ID: 25893439
[TBL] [Abstract][Full Text] [Related]
36. Nonprotective and temperature-sensitive variants of Marek's disease vaccine viruses.
Witter RL; Offenbecker L
J Natl Cancer Inst; 1979 Jan; 62(1):143-51. PubMed ID: 214607
[No Abstract] [Full Text] [Related]
37. Newcastle disease virus (NDV) recombinant expressing the hemagglutinin of H7N9 avian influenza virus protects chickens against NDV and highly pathogenic avian influenza A (H7N9) virus challenges.
Hu Z; Liu X; Jiao X; Liu X
Vaccine; 2017 Dec; 35(48 Pt B):6585-6590. PubMed ID: 29042201
[TBL] [Abstract][Full Text] [Related]
38. Heterologous prime-boost immunization of Newcastle disease virus vectored vaccines protected broiler chickens against highly pathogenic avian influenza and Newcastle disease viruses.
Kim SH; Samal SK
Vaccine; 2017 Jul; 35(33):4133-4139. PubMed ID: 28668574
[TBL] [Abstract][Full Text] [Related]
39. Recombinant Gallid herpesvirus 2 with interrupted meq genes confers safe and efficacious protection against virulent field strains.
Zhang Y; Liu C; Yan F; Liu A; Cheng Y; Li Z; Sun G; Lv H; Wang X
Vaccine; 2017 Aug; 35(36):4695-4701. PubMed ID: 28754487
[TBL] [Abstract][Full Text] [Related]
40. A double recombinant herpes virus of turkeys for the protection of chickens against Newcastle, infectious laryngotracheitis and Marek's diseases.
Gergen L; Cook S; Ledesma B; Cress W; Higuchi D; Counts D; Cruz-Coy J; Crouch C; Davis P; Tarpey I; Morsey M
Avian Pathol; 2019 Feb; 48(1):45-56. PubMed ID: 30404540
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
